文献速递产科母胎医学

罕见常染色体非整倍体筛查阳性增加不良妊娠结局频率并改变临床管理

Screening Positive for Rare Autosomal Aneuploidies Increases Frequency of Adverse Pregnancy Outcomes and Alters Clinical Management.
PubMed 文献 · Prenat Diagn · 2025-03-23

本研究将产前游离DNA筛查结果与去标识保险索赔数据关联,比较682例罕见常染色体非整倍体筛查阳性(RAA+)与阴性(RAA-)妊娠的结局与管理。RAA+组活产率显著更低(56.7% vs. 78.7%,p<0.001),流产率和早产率显著更高(14.8% vs. 3.2%,p<0.001;18.5% vs. 8.9%,p<0.001)。在罕见常染色体三体筛查阳性(RAT+)且结果已知的妊娠中,超声和妊娠相关就诊次数更多。

要点

  • RAA+妊娠活产率56.7%,显著低于RAA-妊娠的78.7%(p<0.001)。
  • RAA+妊娠流产率14.8%、早产率18.5%,均显著高于RAA-组(p<0.001)。
  • RAT+结果已知者超声次数(均值3.7 vs. 2.5,p=0.002)和妊娠相关就诊次数(均值6.6 vs. 5.1,p=0.007)多于结果未知者。

核心结论

  • RAA+妊娠不良结局发生率高于RAA-妊娠,且知晓RAA+结果与更密集的监测相关。

研究设计与样本

  • 将产前游离DNA筛查结果与去标识保险索赔数据关联,比较682例RAA+妊娠与RAA-妊娠的结局与管理。
  • 使用诊断和操作代码估计妊娠结局与管理,比较分析中相关协变量采用倾向性评分匹配校正。
  • 结局采用Mantel-Haenszel检验和McNemar检验进行统计学比较。

主要发现

  • RAA+妊娠活产率56.7%,显著低于RAA-妊娠的78.7%(p<0.001)。
  • RAA+妊娠流产率14.8%,显著高于RAA-妊娠的3.2%(p<0.001)。
  • RAA+妊娠早产率18.5%,显著高于RAA-妊娠的8.9%(p<0.001)。
  • 在RAT+且结果已知的妊娠中,超声次数均值3.7 vs. 2.5(p=0.002),妊娠相关就诊次数均值6.6 vs. 5.1(p=0.007),均多于RAT+结果未知的妊娠。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Outcomes in pregnancies with rare autosomal aneuploidies (RAAs) are poorly characterized, with most studies having small sample sizes. Here, we describe outcomes and management in a large cohort of pregnancies that screened positive for an RAA (RAA+). METHODS: Results of prenatal cell-free DNA screening were linked to de-identified insurance claims data. Diagnosis and procedure codes were used to estimate pregnancy outcomes and management. Relevant covariates in comparative analyses were adjusted using propensity-score matching. Outcomes were statistically compared using Mantel-Haenszel and McNemar's tests. RESULTS: Among 682 RAA+ pregnancies, the rate of live birth was significantly lower (56.7% vs. 78.7%; p < 0.001), and the rates of miscarriage and preterm birth were significantly higher (14.8% vs. 3.2%, p < 0.001; 18.5% vs. 8.9%, p < 0.001; respectively), compared to pregnancies with RAA- results. In pregnancies that screened positive for a rare autosomal trisomy (RAT+) and in which the RAT+ results were known, ultrasounds (mean: 3.7 vs. 2.5, p = 0.002), and pregnancy-specific visits (mean: 6.6 vs. 5.1; p = 0.007) were more frequent compared with pregnancies in which the RAT+ result was unknown. CONCLUSION: Pregnancies with RAA+ results had higher rates of adverse outcomes compared with those with RAA- results, and awareness of RAA+ results was associated with more intensive monitoring.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Chawla D, Miller DC, Pierson S, et al. Screening Positive for Rare Autosomal Aneuploidies Increases Frequency of Adverse Pregnancy Outcomes and Alters Clinical Management. Prenat Diagn. 2025. PMID: 40122782. doi:10.1002/pd.6776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。